Literature DB >> 11053628

Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of CIITA.

P J van den Elsen1, N van der Stoep, H E Viëtor, L Wilson, M van Zutphen, S J Gobin.   

Abstract

Lack of MHC-mediated antigen presenting functions of fetal trophoblast cells is an important mechanism to evade maternal immune recognition. In this study we demonstrated that the deficiency in MHC expression and antigen presentation in the trophoblast cell lines JEG-3 and JAR is caused by lack of class II transactivator (CIITA) expression due to hypermethylation of its interferon-gamma (IFN-gamma)-responsive promoter (PIV). Circumvention of this lack of CIITA expression by introduction of exogenous CIITA induced cell surface expression of HLA-DR, -DP, and -DQ, leading to an acquired capacity to present antigen to antigen-specific T cells. Transfection of CIITA in JEG-3 cells also upregulated functional HLA-B and HLA-C expression. Noteworthy, this lack of IFN-gamma-mediated induction of CIITA was also found to exist in normal trophoblast cells expanded from chorionic villus biopsies. Together, these observations demonstrate that lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053628     DOI: 10.1016/s0198-8859(00)00159-2

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  15 in total

1.  Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity.

Authors:  Philippe Le Bouteiller; Aliz Barakonyi; Jérome Giustiniani; Françoise Lenfant; Anne Marie-Cardine; Maryse Aguerre-Girr; Magali Rabot; Ivan Hilgert; Fathia Mami-Chouaib; Julie Tabiasco; Laurence Boumsell; Armand Bensussan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

Review 2.  HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance.

Authors:  Barbara Seliger; Matthias Kloor; Soldano Ferrone
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

3.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.

Authors:  Suhani Thakker; Pravinkumar Purushothaman; Namrata Gupta; Shanthan Challa; Qiliang Cai; Subhash C Verma
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

4.  Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.

Authors:  T Rodríguez; R Méndez; A Del Campo; N Aptsiauri; J Martín; G Orozco; G Pawelec; D Schadendorf; F Ruiz-Cabello; F Garrido
Journal:  Immunogenetics       Date:  2006-12-20       Impact factor: 2.846

5.  In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner.

Authors:  Philippe Rousseau; Krzysztof Masternak; Michal Krawczyk; Walter Reith; Jean Dausset; Edgardo D Carosella; Philippe Moreau
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

6.  Genomewide association study of HLA alloimmunization in previously pregnant blood donors.

Authors:  Mark Seielstad; Grier P Page; Nathan Gaddis; Marion Lanteri; Tzong-Hae Lee; Ram Kakaiya; Lisa F Barcellos; Lindsey A Criswell; Darrell Triulzi; Philip J Norris; Michael P Busch
Journal:  Transfusion       Date:  2017-11-22       Impact factor: 3.157

7.  Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation.

Authors:  Ann C Morris; Guy W Beresford; Myesha R Mooney; Jeremy M Boss
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

8.  Class II transactivator (CIITA) deficiency in tumor cells: complicated mechanisms or not?

Authors:  Peter J van den Elsen; Nienke van der Stoep
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

Review 9.  HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance.

Authors:  M Campoli; S Ferrone
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

10.  Histone deacetylases inhibit IFN-gamma-inducible gene expression in mouse trophoblast cells.

Authors:  Jason C Choi; Renae Holtz; Shawn P Murphy
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.